MA, SC, and DK were involved in reviewing
J Physiol Paris 94:99104 Sikiric P, Jelovac N, Jelovac-Gjeldum A et al (2001) Anxiolytic effect of BPC-157, a gastric pentadecapeptide: shock probe/burying test and light/dark test
twice-daily injections typical for injectable protocols No refrigeration needed (capsules stable at room temperature) Convenient for travel and busy schedules Dietary supplement status (no prescription required) Injectable Characteristics: Potentially higher bioavailability reaching systemic circulation (comparative human data does not exist) Established user base with extensive anecdotal reports Ability to perform local injection near injury sites Dosing protocols from practitioner guidance more available Consideration: Oral BPC-157 suits needle-averse beginners prioritizing convenience
doi: 10.1159/000324448 83 MasiniEBaniDVannacciAPierpaoliSMannaioniPFComhairSAAet al
In addition, BPC-157 has not been approved by the U.S
When we prescribe peptides, we are targeting specific pathways in your body